High and sustained patient satisfaction¹

What do patients think about DEGARELIX FERRING^3,4?

There is high and sustained patient satisfaction with DEGARELIX FERRING administration.¹

Monthly DEGARELIX FERRING administration was considered satisfactory by 82% of patients (173/211) at 6 months^1*

Satisfaction was sustained during the maintenance phase, with patient satisfaction rate increased to 83.6% (117/140) at 12 months¹

*Patient satisfaction was the secondary endpoint in a multicentre, long-term, prospective, observational, non-interventional study of DEGARELIX FERRING patients in the Netherlands with advanced prostate cancer. The primary endpoint was PFS failure rate.

What are your key criteria for achieving a positive administration experience for patients?

For patients, after 1 year of treatment, regular visits with their healthcare team were reported as important:^1*

perceived seeing their urologist every 3 months as ‘just right’¹

perceived monthly nurse visits for maintenance injections as ‘just right’¹

Injection site reactions occurred mainly with the starting dose; but incidence dropped from 33% to 4% with maintenance injections⁵

For nurses, optimising injection technique could also play an important role in patients’ experience of DEGARELIX FERRING administration^2**

*Patient satisfaction was the secondary endpoint in a multicentre, long-term, prospective, observational, non-interventional study of DEGARELIX FERRING patients in the Netherlands with advanced prostate cancer. The primary endpoint was PFS failure rate.

Secondary endpoints included patient and physician satisfaction scores.

Optimise your injection technique